Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-02

Clinical Trial Update: Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acetazolamide effects on right heart function at rest in COPD patients traveling to high altitude, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Right Heart Function, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: UNKNOWN